#genesis athena

[theresah331]

Privacy and security of genetic information: Putting DNA companies to the test

Some secrets are so secret that no one knows about them. Until recently that described the secrets locked within our DNA.

[theresah331]

New CRISPR Center Brings Hope for Rare and Deadly Genetic Diseases

The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic d

[theresah331]

Casgevy approval unlikely to be followed up by another CRISPR drug in near future

Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, Casgevy.

[theresah331]

CRISPR’s Unintended Cuts: Alarming Findings in Cancer Gene Therapy

New research reveals that CRISPR-Cas9 gene editing can unintentionally lead cancer cells to remove crucial genes, impacting cancer research

[theresah331]

RNA-based anti-CRISPRs - Nature Chemical Biology

[theresah331]

Brain Organoids from Fetal Tissue Take CRISPR Changes, Enable Tumor Modeling

Researchers say fetal tissue-derived organoids can offer novel insights into what shapes the different regions of the brain, and what create

[theresah331]

It's Been An Abysmal Two Years. But Biotech Is Looking Up.

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

[theresah331]

Novel Alzheimer's Trials Evaluate Senolytics, Semaglutide, CRISPR, and More

Looking ahead to 2024 and beyond: 'There is so much more to be done'